Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and Generics. It provides an integrated package of chemical synthesis and biological processing services which clients can use to manage their drug manufacturing projects fully compliant with regulations. We rely on a global network of 11 manufacturing site and 7 R&D departments across the globe, on several decades of experience in supporting pharmaceutical, biotech, food, chemical and bio-industrial companies. Thanks to 2.300 employees and 300 highly experienced and qualified people in R&D team, we are a highly reliable partner. In Olon, expertise and competence are combined with great flexibility at different levels, remarkably in the field of microbial fermentation, always considering human safety and environmental security. The company site located in Settimo Torinese is an historical asset of the global manufacturing network and moreover represents a center of excellence for biotechnological manufacturing.
The University of Turin saw a large participation of 50 researchers from 7 departments.
The Vice Chancellors for Research, Prof. Cristina Prandi and Prof. Alessandro Vercelli were able to discuss with the company the favorable context for boosting collaboration with Olon, linked to the NRRP projects, the EIT Health program in which Unito participates and the strategic initiative on sustainability in the Butterfly Area.
The event, organized by the Industrial Liaison Office of the Unito Innovation and Internationalization Department, is part of the University’s plan to strengthen its strategic alliances with local and national businesses.
Olon meets Unito
